These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 23732810)
1. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Arulmozhi V; Pandian K; Mirunalini S Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810 [TBL] [Abstract][Full Text] [Related]
2. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats. Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy. Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511 [TBL] [Abstract][Full Text] [Related]
4. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study. Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262 [TBL] [Abstract][Full Text] [Related]
5. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834 [TBL] [Abstract][Full Text] [Related]
7. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles. Mady FM; Shaker MA Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891 [TBL] [Abstract][Full Text] [Related]
8. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release. Hu X; Wang Y; Peng B Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568 [TBL] [Abstract][Full Text] [Related]
9. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines. Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078 [TBL] [Abstract][Full Text] [Related]
10. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. Yallapu MM; Gupta BK; Jaggi M; Chauhan SC J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257 [TBL] [Abstract][Full Text] [Related]
11. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Kim S; Gaber MW; Zawaski JA; Zhang F; Richardson M; Zhang XA; Yang Y Biomaterials; 2009 Sep; 30(27):4743-51. PubMed ID: 19501395 [TBL] [Abstract][Full Text] [Related]
12. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells. Manju S; Sreenivasan K Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497 [TBL] [Abstract][Full Text] [Related]
13. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug. Jang MK; Jeong YI; Nah JW Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles. Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445 [TBL] [Abstract][Full Text] [Related]
15. [Preparation and characterization of biotinylated chitosan nanoparticles]. Yao Q; Hou SX; Zhang X; Zhao G; Gou XJ; You JZ Yao Xue Xue Bao; 2007 May; 42(5):557-61. PubMed ID: 17703783 [TBL] [Abstract][Full Text] [Related]
16. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388 [TBL] [Abstract][Full Text] [Related]
17. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
18. A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Kim S; Nishimoto SK; Bumgardner JD; Haggard WO; Gaber MW; Yang Y Biomaterials; 2010 May; 31(14):4157-66. PubMed ID: 20185170 [TBL] [Abstract][Full Text] [Related]
19. Preparation of polysaccharide derivates chitosan-graft-poly(ɛ-caprolactone) amphiphilic copolymer micelles for 5-fluorouracil drug delivery. Gu C; Le V; Lang M; Liu J Colloids Surf B Biointerfaces; 2014 Apr; 116():745-50. PubMed ID: 24529474 [TBL] [Abstract][Full Text] [Related]
20. Investigation on novel chitosan nanoparticle-aptamer complexes targeting TGF-β receptor II. Chen X; Zhu X; Li L; Xian G; Wang W; Ma D; Xie L Int J Pharm; 2013 Nov; 456(2):499-507. PubMed ID: 23999222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]